
Invited Speakers

Program
Wednesday 3rd May, 2023
08:00-08:45
08:45-09:30
Registration, Gathering and Exhibition
Opening Ceremony- Honored by the President of the State of Israel
His Excellency Mr. Isaac Herzog
Honored by the presence of the Davidoff Family
09:30-11:15
Session 1
Chairpersons: Dr. Ofir Wolach & Dr. Itai Levi
09:30-10:00- How I treat ALL at MD Anderson in 2023
Hagop Kantarjian, MD, MD Anderson, Houston, USA
10:00-10:05 - Q&A
10:05-10:40 - Are we ready for risk-adapted therapy in CML
Timothy Hughes, MD, SAHMRI Beat Cancer, University of Adelaide, Australia
10:40-11:15 - Novel prediction models in cancer associated thrombosis
Jeffrey I. Zwicker, MD,Memorial Sloan Kettering Cancer Center, NY, USA


Coffee Break
11:15-11:45
11:45-12:00
Greetings
Session 2
12:00-13:45
Chairpersons: Dr. Avi Leader & Dr. Tamar Tadmor
12:00-12:35 - Personalized induction strategies for AML
Gail J. Roboz, MD, Weill Cornell Medicine, The New York Presbyterian Hospital, New York, USA
12:35-13:10 - Updates in T cell lymphoma with focus on emerging cellular therapies
Swaminathan Padmanabhan Iyer, MD, MD Anderson, Houston, USA
13:10-13:45- Present and future of molecular testing in CML
Simona Soverini, Ph.D, Alma Mater Studiorum Universita di Bologna, Italy

13:45-15:00
Lunch Break & Guided museum tour
15:00-17:20
Session 3
Chairpersons: Dr. Anat Gafter- Gvili & Dr. Luliana Vaxman
15:00-15:35 - Acute lymphoblastic leukemia at a single base resolution
Gidi Rechavi, MD, Ph.D, Sheba Cancer Research Center, Tel-Hashomer, Israel
15:35-16:10 - Moving towards personalized therapy for Hodgkin lymphoma
Alison Moskowitz, MD, Memorial Sloan Kettering Cancer Center, NY,USA
16:10-16:45 - When not to transplant in ALL?
Elias Joseph Jabbour, MD, MD Anderson, Houston, USA
16:45-17:20- Should high risk smoldering myeloma be treated outside of a clinical trial?
Morie Gertz, MD, Mayo Clinic, Rochester Minnesota, USA


17:20-17:30
Closing Remarks
Thursday 4th May, 2023
08:00-08:50
Registration, Gathering and Exhibition
08:50-10:45
Session 4
Chairperson: Dr. Tzila Zuckerman & Dr. Avichai Shimoni
08:50-09:00 - Opening Remarks
09:00-09:35 - HMA/VEN...and then?
Richard Stone, MD, Dana Farber, Boston, USA
09:35-10:10 - Dormancy as a mechanism of innate resistance to therapy in myeloid malignancies Michael Deininger, MD, Versiti, USA
10:10-10:45 - Ph+ ALL today
Robin Foa, MD, "Sapienza" University of Rome, Italy

10:45-11:15
Coffee Break

11:15-13:00
Session 5
Chairpersons: Dr. Merav Leiba & Dr. Nadav Sarid
11:15-11:50 - From broad to ultra targeted therapeutic approaches in CML: which one is best?
Delphine Rea, MD, Hôpital Saint Louis, Paris, France
11:50-12:25 - CML treatment discontinuation in clinical practice: how can we ameliorate its feasibility?
Giuseppe Saglio, MD, University of Turin, Italy
12:25-13:00- Lymphoma/cellular therapy
Loretta Nastoupil, MD, MD Anderson, Houston, USA
13:00-14:15
Lunch Break & Guided museum tour


14:15-17:20
Session 6
Chairpersons: Dr. Moshe Gatt & Dr. Ariel Aviv
14:15-14:50 - Anticoagulant-related bleeding in Cancer
Kristen Sanfilippo, MD, Washington University School of Medicine in St. Louis,USA
14:50-15:25 - T-cell lymphoma
Steve Horwitz, MD, Memorial Sloan Kettering Cancer Center NY, USA
15:25-16:00 - Advances and remaining challenges for patients with Follicular Lymphoma
Gilles Salles, MD, Memorial Sloan Kettering Cancer Center NY, USA
16:00-17:35 - Novel agents in CLL: better sequenced or combined
Jan Burger, MD, MD Anderson, Houston, USA
17:35-18:10 - The changing landscape of artificial intelligence applications in Hematology
Roni Shouval, MD, Memorial Sloan Kettering Cancer Center NY, USA




18:10-18:20
Closing Remarks
Friday 5th May, 2023
09:00-12:00- Round Table Symposiums
09:00-10:00- CLL and Plasma Cell Dyscrasias
Participants:
-
Jan Burger, MD, Houston, USA
-
Morie Gertz, MD, Rochester, USA
-
Tamar Tadmor, MD, Haifa, Israel
-
Iuliana Vaxman, MD, Petah-Tikva, Israel
-
Gilad Itchaki, MD, Petah-Tikva, Israel \
10:00--11:00- Chronic Myeloid Leukemia
Participants:
-
Simona Soverini, Ph.D, Bologna, Italy
-
Giuseppe Saglio, MD, Turin, Italy
-
Pia Raanani, MD, Petah- Tikva, Israel
-
Mr. Giora Sharf, Expert Patient Advocate, Israel
-
Adi Shacham-Abulafia, MD, Petah- Tikva, Israel
11:00-12:00- Acute Leukemia
Participants:
-
Hagop Kantarjian, MD, Houston, USA
-
Gail Roboz, MD, New York, USA
-
Richard Stone, MD, Boston, USA
-
Robin Foa, MD, Rome, Italy
-
Ofir Wolach, MD, Petah-Tikva, Israel

